This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC Injections | MicrobiomeTrials
← Back to trials NCT07811999
Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC Injections Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09-22Est. Completion: 2027-01-14
Enrollment target: 308 participantsOther microbiome trials you might be interested in Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United States Est. completion Jun 1, 2036
Overweight and Obese Adults
Obesity is a complex disease and a major risk factor for cardiovascular and metabolic disorders, particularly atheroscle…
Istanbul, Turkey (Türkiye) Est. completion Sep 30, 2026
Cryptococcal Infection Cryptococcal Pneumonia Pulmonary Cryptococcosis Cryptococcal Meningitis Cryptococcosis
The protocol will be carried out in accordance with International Council for Harmonisation of Technical Requirements fo…